Target intelligence / Profile preview

Kalirin (RhoGEF kinase) (KALRN)

Target
KALRN
Molecular classification
Guanine nucleotide exchange factor (GEF), Enzyme, RhoGEF, Serine/threonine-protein kinase, Dbl family protein, Multi-domain scaffold protein
01

Overview

Kalirin is a multidomain scaffold protein encoded by the KALRN gene, primarily known for its function as a guanine nucleotide exchange factor (GEF) that activates Rho-family small GTPases, such as Rac1, RhoG, and RhoA[1][2][3][5]. It contains multiple functional domains, including Dbl homology (DH) and pleckstrin homology (PH) regions, and can also exhibit serine/threonine kinase activity. Kalirin has numerous isoforms resulting from alternative splicing, with Kalirin-7, -9, and -12 being most prevalent in the brain. It plays a critical role in neurite outgrowth, dendritic spine formation, and synaptic plasticity, and is involved in the development and function of neuronal circuits. The biological significance of Kalirin is underscored by its association with diseases involving synaptic dysfunction or cognitive impairment, including schizophrenia and autism spectrum disorder. Loss-of-function or variant mutations in KALRN have been shown to impair synaptic connectivity and function[1][2][3][4][5]. Kalirin also interacts with numerous synaptic proteins, such as NMDA receptor subunits and DISC1, regulating synaptic strength and plasticity. Although not yet the direct target of approved drugs, its central role in nervous system pathology makes it a potential therapeutic target in neuropsychiatric and neurodegenerative diseases[1][2][3][5].

Other names
DUETDUOHAPIPTRADHuntingtin-associated protein-interacting proteinProtein DuoSerine/threonine-protein kinase with Dbl- and pleckstrin homology domainARHGEF24KALNC2
02

Mechanism of action

Modulation of RhoGTPase activity (predominantly Rac1, also RhoG and RhoA) via exchange of GDP for GTP Promotion or inhibition of synaptic plasticity Alteration of dendritic spine morphology and number

03

Biological functions

Signal transductionCytoskeletal remodelingRegulation of neurite outgrowthDendritic spine formationSynaptic plasticityCell motilityCell polarity
04

Disease associations

Neurodegenerative diseasePsychiatric disorders (e.g., schizophrenia, autism spectrum disorder)Cognitive impairmentCardiovascular disease (limited evidence)
05

Safety considerations

Targeting can affect synaptic plasticity and cognitive functionRisk of altered neuronal connectivity leading to neuropsychiatric symptomsPotential impact on vascular function (with specific isoforms)
06

Interacting drugs

None clearly established; no approved drugs directly target Kalirin. Some experimental compounds and small molecules (such as Rac pathway inhibitors) may indirectly modulate Kalirin signaling
07

Biomarkers

Kalirin protein/isoform levels in neural tissues (potential marker for synaptopathies and psychiatric/neurodegenerative conditions)

Beyond the preview

Go deeper on Kalirin (RhoGEF kinase) (KALRN).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kalirin (RhoGEF kinase) (KALRN).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call